Home About
Fitness Precision Medicine Recovery Mental Performance MedLab MedSpa
Explore All Blog Getting Started Join Waitlist
ALYZE Peptide Therapy
Precision Medicine

Peptide Therapy

Peptides are short chains of amino acids that act as signaling molecules — instructing your body to heal, regenerate, and optimize. From growth hormone secretagogues to tissue-repair compounds, ALYZE deploys targeted peptide protocols informed by your biomarkers.

Benefits Usage Guide Research
Health Benefits

Why peptides?

Therapeutic peptides represent one of the fastest-growing areas of precision medicine. Here's what the research demonstrates.

Tissue Repair & Healing

BPC-157, a gastric pentadecapeptide, accelerates healing of tendons, ligaments, muscles, and bones. It upregulates growth hormone receptor expression and activates angiogenic pathways critical for tissue regeneration.

+42%

Growth Hormone Optimization

CJC-1295 produces sustained, dose-dependent increases in GH and IGF-1 levels while preserving natural pulsatile secretion patterns. Unlike exogenous GH, secretagogue peptides work with your body's own signaling.

Neuroprotection

BPC-157 interacts with dopamine, serotonin, glutamate, GABA, and nitric oxide systems — counteracting disturbances related to receptor blockade, over-activity, depletion, tolerance, and sensitization.

Selective GH Release

Ipamorelin is the first growth hormone secretagogue with selectivity similar to GHRH — it potently releases GH without significantly elevating cortisol or ACTH, even at doses 200-fold above the effective GH-releasing dose.

200×

Wound Healing & Recovery

Thymosin Beta-4 promotes cell migration, angiogenesis, and stem cell differentiation. Phase 2 clinical trials demonstrated accelerated dermal healing — nearly a month faster in patients with chronic wounds.

Anti-Inflammatory Action

Thymosin Beta-4 downregulates inflammatory chemokines and cytokines including IL-1, IL-6, and TNF. In sepsis models, it significantly reduced mortality and lowered circulating inflammatory mediators.

Usage Guide

How we approach peptide therapy.

01

Clinical Assessment

Your ALYZE practitioner evaluates your health goals, current biomarkers, and medical history to determine which peptides — and which combinations — are appropriate for your protocol.

02

Protocol Design

Peptide protocols are highly individualized. Your practitioner selects the right peptide(s), dosing schedule, and administration route — subcutaneous injection, oral, or topical — based on your specific needs.

03

Administration Training

Many peptide protocols involve self-administered subcutaneous injections. Your ALYZE team provides hands-on training with proper injection technique, storage instructions, and reconstitution procedures.

04

Cycling & Monitoring

Most peptide protocols follow specific cycling patterns — periods of use followed by rest. Your practitioner monitors biomarkers including IGF-1, inflammatory markers, and healing progress to optimize your cycle.

05

Protocol Evolution

As your body responds, your peptide protocol evolves. Some peptides may be tapered, new ones introduced, or dosing adjusted based on your labs and clinical response. The goal is targeted, time-limited intervention.

Pro Tips

  • GH-releasing peptides are most effective when administered on an empty stomach, typically before bed
  • Store reconstituted peptides in the refrigerator and use within the timeframe specified by your practitioner
  • BPC-157 can be taken orally for GI-related benefits or injected subcutaneously near the site of injury
  • Combine GH secretagogue peptides with quality sleep for synergistic growth hormone release
  • Rotate injection sites to prevent tissue irritation
  • Track your recovery metrics — peptide effects are often measurable within 2–4 weeks
  • Your ALYZE protocol may integrate peptides with your fitness and recovery plans for compounding results

Important: Peptide therapy must be prescribed and supervised by a licensed medical provider. Only use peptides sourced from licensed compounding pharmacies through your ALYZE practitioner. Self-sourcing peptides from unregulated suppliers carries significant contamination and dosing risks. Peptide therapy may be contraindicated in individuals with active cancer or certain autoimmune conditions. Report any injection site reactions, unusual swelling, or systemic symptoms to your practitioner immediately.

Clinical Research

The evidence.

Peptide therapy draws from a growing body of preclinical and clinical research. These are key peer-reviewed studies across the major therapeutic peptides.

BPC-157 · Tissue Repair

Gastric Pentadecapeptide Body Protection Compound BPC 157 and Its Role in Accelerating Musculoskeletal Soft Tissue Healing

Cerovecki et al. · Marine Drugs · 2019
BPC-157 has huge potential for therapy of hypovascular and hypocellular soft tissues such as tendons and ligaments. It promotes healing through its own angiogenic effects, accurately implementing tissue repair mechanisms.
View on PubMed →
BPC-157 · Growth Hormone Receptor

Pentadecapeptide BPC 157 Enhances the Growth Hormone Receptor Expression in Tendon Fibroblasts

Chang et al. · Molecules · 2014
BPC-157 dose- and time-dependently increased growth hormone receptor expression in tendon fibroblasts at both mRNA and protein levels, activating the downstream JAK2 signaling pathway of growth hormone.
View on PubMed →
CJC-1295 · GH Optimization

Prolonged Stimulation of Growth Hormone and IGF-I Secretion by CJC-1295, a Long-Acting Analog of GH-Releasing Hormone, in Healthy Adults

Teichman et al. · Journal of Clinical Endocrinology & Metabolism · 2006
Subcutaneous CJC-1295 produced sustained, dose-dependent increases in GH and IGF-I levels in healthy adults and was safe and well tolerated, with a half-life of approximately 8 days.
View on PubMed →
Ipamorelin · Selectivity

Ipamorelin, the First Selective Growth Hormone Secretagogue

Raun et al. · European Journal of Endocrinology · 1998
Ipamorelin displays high GH-releasing potency without significantly releasing ACTH or cortisol, even at doses more than 200-fold higher than the ED50 for GH release — the first GHRP-receptor agonist with selectivity similar to GHRH.
View on PubMed →
Thymosin Beta-4 · Wound Healing

The Regenerative Peptide Thymosin Beta-4 Accelerates the Rate of Dermal Healing in Preclinical Animal Models and in Patients

Philp et al. · Annals of the New York Academy of Sciences · 2012
In two Phase 2 clinical trials of stasis and pressure ulcers, thymosin beta-4 accelerated healing by nearly a month in patients who healed. Preclinical models showed increased re-epithelialization by up to 61%.
View on PubMed →
Sermorelin · Growth Hormone

Sermorelin: A Review of Its Use in the Diagnosis and Treatment of Children with Idiopathic Growth Hormone Deficiency

Kemp & Frindik · BioDrugs · 2007
Sermorelin, a 29-amino-acid analogue of GHRH with full biological activity, specifically stimulates pituitary GH secretion. Significant increases in height velocity were sustained during 12 months of treatment and maintained through 36 months.
View on PubMed →

Latest research.

Recent peer-reviewed studies on therapeutic peptides, automatically sourced from PubMed.

Auto-updated from PubMed

Loading latest research...
ALYZE facility
ALYZE facility
ALYZE facility
ALYZE facility

Optimize your

recovery.
longevity.
healing.
health.
recovery.
Join the Waitlist

Bountiful, Utah · alyze.health

The information provided on this page is for general informational and educational purposes only and is not intended as medical advice. The research cited is from peer-reviewed journals and is presented for educational purposes. Individual results may vary. Always consult with a qualified healthcare provider before beginning any new wellness practice, including peptide therapy.